Hann CL, Burns TF, Dowlati A, Morgensztern D, et al. Brief Report: A Phase 1 Study Evaluating Rovalpituzumab Tesirine (Rova-T) in Frontline Treatment of Patients With Extensive-Stage Small Cell Lung Cancer. J Thorac Oncol 2021 Jul 6. pii: S1556-0864(21)02289.
PMID: 34242790